All News

Found 3,490 articles

• Mersana Therapeutics, Inc. Earns Milestone Payment in Fleximer-ADC Collaboration With Endo Pharmaceuticals

  10/15/2013

• Sorrento Therapeutics, Inc. Acquires Clinical Stage Drug Candidate for Treatment of Chronic Pain

  10/11/2013

• ImmunoGen, Inc., Novartis AG Announce New License Agreement

  10/11/2013

• Molecular Templates Inc. Announces $8.5 Million Series C Financing and $10.6 Million Grant Funding

  10/8/2013

• CPhI Annual Expert Industry Report: Part I

  10/2/2013

• ImmunoGen, Inc. Announces Results from Kadcyla® Phase III Trial, TH3RESA, Being Presented Today at the European Cancer Congress

  9/30/2013

• ImmunoGen, Inc. Announces Positive Regulatory Decisions for Roche's Kadcyla® in the European Union and Japan

  9/20/2013

• Sorrento Therapeutics, Inc. Announces a Presentation on Cynviloq&#0153 at the AACR Conference on Advances in Ovarian Cancer Research: From Concept to Clinic

  9/16/2013

• Sorrento Therapeutics, Inc. Completes IgDraSol Merger

  9/10/2013

• Sorrento Therapeutics, Inc. Secures Rights to Biomiga Diagnostics' Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy

  9/10/2013

• Sorrento Therapeutics, Inc. to Present at Two Healthcare Conferences

  9/6/2013

• ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences

  9/4/2013

• Sangamo BioSciences, Inc. to Acquire Ceregene, Inc.

  8/27/2013

• ImmunoGen, Inc. Announces Executive Change

  8/27/2013

• Ambrx, Inc. Appoints Peter Kiener, Ph.D., as Chief Scientific Officer

  8/20/2013

• ImmunoGen, Inc. Announces FDA Acceptance of IND for Company's Novel EGFR-Targeting ADC, IMGN289

  8/2/2013

• ImmunoGen, Inc. Reports Fourth Quarter and Fiscal Year 2013 Financial Results and Provides Fiscal Year 2014 Financial Guidance and Corporate Update

  8/2/2013

• Serina Therapeutics, Inc. Announces Agreement With The Scripps Research Institute for Development of Polymer-Antibody Drug Conjugates

  7/31/2013

• AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer's Disease

  7/23/2013

• ADC Therapeutics Licenses Proprietary Antibody From BZL Biologics for Prostate Cancer

  7/15/2013